Some of the specific applications of necroptosis in cancer therapy include necroptosis-inducing drugs, necroptosis inhibitors (receptor-interacting serine/threonine-protein kinase (RIPK)1 inhibitors, RIPK3 inhibitors, MLKL inhibitors), and necrotic cell debris removal. The gene discussed is RIPK1; the disease is cancer.